Synovial sarcoma is a morphologically, clinically and genetically distinct entity that accounts for 5-10% of all soft tissue sarcomas. The t(X;18)(p11.2;q11.2) is the cytogenetic hallmark of synovial sarcoma and is present in more than 90% of the cases. It produces three types of fusion gene formed in part by SS18 from chromosome 18 and by SSX1, SSX2 or, rarely, SSX4 from the X chromosome. The SS18-SSX fusions do not seem to occur in other tumor types, and it has been shown that in synovial sarcoma a clear correlation exists between the type of fusion gene and histologic subtype and, more importantly, clinical outcome. Previous analyses regarding the type of fusion genes have been based on PCR amplification of the fusion transcript, requiring access to goodquality RNA. In order to obtain an alternative tool to diagnose and follow this malignancy, we developed a fluorescence in situ hybridization (FISH) assay that could distinguish between the two most common fusion genes, that is, SS18-SSX1 and SS18-SSX2. The specificity of the selected bacterial artificial chromosome clones used in the detection of these fusion genes, as well as the sensitivity of the analysis in metaphase and interphase cells, was examined in a series of 28 synovial sarcoma samples with known fusion gene status. In all samples, the type of fusion was correctly identified by FISH. Thus, the assay described here should be useful for clarifying unresolved chromosome markers and for identifying fusion gene status in samples from which RNA of sufficient quality for PCR could not be extracted.
Synovial sarcoma accounts for 5-10% of all soft tissue sarcomas. 1 It is most prevalent in adolescents and young adults between 15 and 40 years of age, occurs predominantly in males, and is often found in juxta-articular locations, particularly in the area of the knee. However, synovial sarcoma occasionally occurs in areas with no apparent relationship to synovial structures, such as the head and neck region and the trunk.
Histologically, synovial sarcoma may be subdivided into four variants, the biphasic and the monophasic subtypes being the most common. Biphasic synovial sarcoma is characterized by epithelial and spindle cell components in varying proportions, whereas the monophasic type has a spindle cell component alone. Monophasic epithelial and poorly differentiated subtypes have also been discerned, but are much less common. Poorly differentiated synovial sarcoma, in particular, poses a diagnostic problem, as it is difficult to distinguish from other round cell sarcomas. Thus, molecular genetic techniques may be useful in reaching a correct diagnosis. 2 The t(X;18)(p11.2;q11.2) is the cytogenetic hallmark of synovial sarcoma, being present in more than 90% of all the cases reviewed in the literature. [3] [4] [5] It produces three types of fusion gene formed in part by SS18 (also known as SYT) from chromosome 18 and by SSX1, SSX2 or SSX4 from the X chromosome. 6 The SS18-SSX fusion gene is always retained during tumor progression and is transcribed from the der(X) chromosome. In the oncogenic fusion protein, the eight carboxy (C)-terminal amino acids of SS18 are replaced with the last 78 amino acids of SSX. 7 It has previously been shown that a correlation exists between histologic subtype and type of fusion gene, with biphasic and monophasic histologies being more characteristic of the SS18-SSX1 and SS18-SSX2 fusions, respectively. 8 Furthermore, patients with SS18-SSX1 fusion genes have a worse clinical outcome than patients with SS18-SSX2-positive tumors. 9 The SS18-SSX4 fusion gene is much less frequent than the other two types, making up less than 1% of the cases, and nothing is known about its clinical impact. 9, 10 Although the different SS18-SSX fusion genes, as well as the variant reported in a single case, 11 are readily detected by reverse transcriptasepolymerase chain reaction (RT-PCR), sufficient amounts of good-quality RNA may not always be available. Thus, we wanted to develop a fluorescence in situ hybridization (FISH) assay that could distinguish between the two most common fusion genes, that is, SS18-SSX1 and SS18-SSX2. For this purpose, we identified bacterial artificial chromosome (BAC) clones, specific for the SSX1, SSX2 and SS18 genes, which should allow the detection of synovial sarcoma fusion genes by FISH not only in metaphase cells, but also in interphase cells. The specificity of these probes, as well as the sensitivity of the analysis, was examined in a series of 28 synovial sarcoma samples with known fusion gene status.
Materials and methods
A total of 28 samples from 21 patients with synovial sarcoma were processed for FISH investigations. From three patients, multiple (2-5) samples were investigated. Culturing, harvesting of tumor cells and chromosome banding were performed as previously described. 12 The karyotypes were described according to the International System for Human Cytogenetic Nomenclature. 13 All the samples were analyzed beforehand by RT-PCR, as reported elsewhere, 14 in order to detect the type of fusion gene (SS18-SSX1 or SS18-SSX2). The clinical, cytogenetic and molecular features are listed in Table 1. FISH was carried out as described. 15 The following BAC clones were used as probes in the FISH experiments:
RP11 In the present FISH analysis, a pool of BAC probes mentioned before spanning the SSX1and SSX4 genes was cohybridized with a pool of BACs covering the entire SSX2 gene and with a pool of BAC probes specific for the SS18 gene in order to recognize, in a single hybridization experiment, if an SS18-SSX1 or an SS18-SSX2 fusion gene was formed. These clones were selected with the aim of covering more than the entire length of the involved genes. Hence, wherever the breakpoints are located in the SSX1, SSX2 and SS18 genes, the two parts originating from the splitting of the pools of BAC probes would always be large enough to be detected by FISH. This is particularly important for revealing fusion genes in cases with unusual breakpoints or with more complex translocations, for example, three-way translocations.
All the BAC clones were tested one by one on metaphase and interphase cells of healthy donors in order to analyze the strength of the signals, the lack of crosshybridization or chimeric signals and the absence of background. Then, the pools of clones were also cohybridized on normal male cells with the purpose of evaluating the pattern of the FISH signals and the efficiency of the probes when used together. The results of the latter experiment are shown in Figure 1a .
Then, 28 samples of synovial sarcoma were analyzed. These samples had been selected so as to include both SSX1-and SSX2-positive cases, as well as one of the very rare cases with the SS18-SSX4 fusion gene, and to represent both cytogenetically simple and complex variants of the t(X;18). All signal observations were performed in a blinded manner, without knowing the results of the karyotypic or RT-PCR analyses. A total of 10 metaphases and 50 interphase nuclei for each case were counted. Signals in overlapping and incomplete nuclei were not recorded. A schematic illustration of the expected FISH signals in normal male and female nuclei and in nuclei carrying the translocation t(X;18)(p11.2;q11.2), together with the ideograms of the rearranged chromosomes, is shown in Figure 2 .
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Results
In the present study, metaphase and interphase nuclei from 28 synovial sarcoma samples with known fusion gene status were analyzed with FISH probes specific for the SSX1, SSX2 and SS18 loci. In all samples, the type of fusion gene was correctly identified by FISH (Table 1) . At FISH, 19 samples showed a simple translocation t(X;18)(p11.2;q11.2), with the formation of SS18-SSX1 (10 samples) or SS18-SSX2 (nine samples) fusion genes. In the samples displaying the SS18-SSX1 fusion, the distinctive features were the splitting of the SSX1 (red) and SS18 (green) signals into two parts and the colocalization of SSX1 and SS18 (red þ green) signals, as observed both in metaphase and interphase cells (Figure 1b-d) . In the samples with a breakpoint in SSX2, the splitting of the SSX2 (violet) and SS18 (green) signals and the colocalization of SSX2 and SS18 (violet þ green) signals were always detected (Figure 1e and f) . Each case showed only one type of fusion gene and was always consistent with the results of the cytogenetic and RT-PCR studies.
Nine samples displayed variant hybridization patterns. Sample 4 was t(X;18)-negative and showed a highly complex karyotype with many unresolved aberrations at cytogenetic analysis, but it was positive for the SS18-SSX1 fusion gene by RT-PCR. FISH revealed the SS18-SSX1 fusion gene in 40% of the metaphase cells, but not in interphase cells due to the high number of normal cells. Thus, a cryptic rearrangement involving the SS18 and SSX1 genes had occurred, but the chromosomal location of the fusion gene could not be determined.
Sample 5 exhibited the expected pattern of SS18-SSX2 FISH signals, but in 80% of the metaphase cells the der(18) was longer than usual, suggesting a more complex translocation involving also chromosome 7. The remaining 20% of the metaphase cells displayed an ordinary t(X;18). Sample 7 showed an atypical pattern of FISH signals because, in addition to the expected SS18-SSX2 fusion gene on the der(X) and the SS18 green signal on the normal chromosome 18, it displayed two SS18 signals on two marker chromosomes and two SSX1 and SSX2 signals on two other markers. No colocalization of green, violet and red signals was seen, indicating the absence of a der (18) .
Sample 10 was at G-banding analysis interpreted to have two copies of a der(X)t(X;18), but no der(18)t(X;18). However, FISH experiments using centromeric and whole chromosome painting probes specific for chromosomes X and 18 revealed also the der(18)t(X;18) and a third chromosome carrying a part of the X chromosome. The colocalization of the three signals specific for the SS18, SSX1 and SSX2 genes, consistent with an SSX2-SS18 fusion gene, was seen on the der (18) .
Sample 11 displayed a karyotype that at G-banding was interpreted to contain a balanced 20 P F SSX1 45,X,t(X;18)(p11;q11),add(1)(p34),del(3)(p13), der (10) SS18-SSX in synovial sarcoma C Surace et al t(X;18), and RT-PCR identified an SS18-SSX1 fusion gene. However, apart from displaying a typical der(X), FISH studies revealed a more complex rearrangement of the der(18), which exhibited a split and/or duplicated SS18 signal, but no SSX1 signal, and which was rearranged with a third chromosome that displayed the SSX1 signal. What was originally interpreted as the der (18)t(X;18) turned out to be a der(?) consisting in most part of chromosome X material. Sample 15, in addition to the colocalization of three signals on the der(X) and the SS18 green signal on chromosome 18, displayed the green and red signals specific for the SS18 and SSX1 genes on two different chromosomes. The karyotype showed a complex translocation t(X;20;8;15;18), which was in agreement with this variant pattern of FISH signals.
In samples 13, 14 and 16-21 only interphase nuclei were analyzed. In sample 13, the nuclei showed colocalization of the SS18 and SSX1 signals, but the RT-PCR results had revealed an SS18-SSX4 fusion gene. The FISH data fit with the RT-PCR results because SSX4 is located close to SSX1 and was included in BAC clone RP11-344N17, the most proximal clone among the three clones of the pool used for SSX1.
In sample 14, almost 3/4 of the nuclei (72%) showed the colocalization of signals specific for the SS18 and SSX2 genes, but not the colocalization of green, violet and red signals. This is consistent with the complex translocation between the chromosomes X, 16 and 18, as shown by G-banding.
In sample 21, the signal for SSX2 was split and colocalized with the signal for SS18. No signal pattern corresponding to a der(18)t(X;18) was seen, in agreement with the cytogenetic findings.
Discussion
In the present study, we used eight BAC clones covering the genes SSX1, SSX2 and SS18 to identify the type of fusion gene (SS18-SSX1 or SS18-SSX2) in 28 synovial sarcoma samples. Since the identification of the SSX and SS18 genes, 6, 16 this is, to our knowledge, the largest series of synovial sarcoma samples screened for the type of fusion gene by FISH. Previously, FISH assays have been performed 
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C Surace et al with whole chromosome painting, alphoid, YAC, PAC and cosmid probes, mainly with the purpose of detecting the t(X;18), irrespective of the type of SSX gene involved. [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] The BAC clones that we selected allowed us not only to detect a simple t(X;18), but also more complex variant translocations. In fact, at FISH analysis, only 19/28 samples displayed a simple t(X;18), whereas the remaining nine samples showed further aberrations. The former consisted of 10 samples having the SS18-SSX1 fusion gene and nine samples with SS18-SSX2. Among the samples with more complex rearrangements, three showed the SS18-SSX1 fusion gene, five had SS18-SSX2 and one displayed SS18-SSX4. We never observed the presence of both SS18-SSX1 and SS18-SSX2 fusion genes in the same sample, which is in contrast to a recent publication in which RT-PCR and FISH findings were interpreted to suggest the simultaneous occurrence of the two fusion genes in a subset of synovial sarcoma. 30 This discrepancy could be due to chance; as only 10% of the cases reported by Yang et al 30 were positive for both SS18-SSX1 and SS18-SSX2, such cases might not have been included in our series. On the other hand, synovial sarcomas expressing more than one fusion gene have not been reported by others, why artefacts from nested RT-PCR must be considered a possible explanation for this phenomenon.
In the present study, we had included one of the very rare cases of synovial sarcoma with the SS18-SSX4 gene. Obviously, this type of fusion could not be distinguished from the SS18-SSX1 fusion gene because the SSX4 gene is included in the clone RP11-344N17, the most proximal clone in the BAC pool used for the detection of SSX1 rearrangement. Since SSX1 is contained in the clone RP11-552E4, the separate use of RP11-552E4 or RP11-344N17 could, theoretically, distinguish between SSX1 and SSX4 rearrangements. However, bearing in mind the low frequency of SS18-SSX4 fusions, we preferred to add the RP11-344N17 clone in order to obtain strong and unequivocal split signals. Furthermore, there are so far no data indicating that patients with SS18-SSX4-positive synovial sarcoma should have a better prognosis than those with SS18-SSX1-positive tumors.
In almost all the cases, the percentage of interphase cells showing SS18-SSX1 or SS18-SSX2 fusion gene by FISH was lower than in the corresponding metaphase cells. Most probably, there are several explanations for this discrepancy. First, a higher mitotic activity of the t(X;18)-carrying cells in vitro would lead to a relative enrichment of sarcoma cells among the dividing cells. Second, hybridization patterns are in general more difficult to interpret at the interphase level than at the metaphase level, especially in cases with complex rearrangements. Third, interphase nuclei often yield signals that are located in different planes, making them difficult to capture simultaneously in the microscope. Hence, the interpretation of FISH signals was sometimes not straightforward, especially in the samples displaying complex chromosome rearrangements. However, because the FISH assay that we set up is based on the simultaneous detection of split signals for the involved genes and their colocalization, we were able to minimize the problems in interpreting unusual hybridization patterns that may arise from, for example, polyploidization or three-way translocations. Furthermore, it should be noted that the cases that were included in our study were selected not only on the basis of their SS18-SSX fusion status, but also so that as many complex karyotypes and varieties of chromosome X and 18 rearrangements as possible could be analyzed. In an unselected series of synovial sarcoma, the frequency of cases with an ordinary t(X;18) would be expected to be much higher.
Thus, apart from being a valuable tool, complementary to RT-PCR and independent on RNA degradation, in characterizing the status of the SSX and SS18 genes in metaphase spreads, the results from interphase nuclei also suggest that the BAC probes can be employed in FISH studies on archived samples.
